parenteral


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

parenteral

[pər′ent·ə·rəl]
(medicine)
Outside the intestine; not via the alimentary tract.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The MEA Parenteral Nutrition Market is expected to display a CAGR of 7.1% in the forthcoming period owing to variables such as increase in premature births, vulnerability to malnutrition, and increasing prevalence of cancers.
"Among discharged patients, a parenteral dose of antibiotics did not reduce revisits leading to admission, supporting the goal of discharging patients with oral antibiotics alone for most children with UTIs," the authors write.
180 mice were divided into control group (30 mice), WT mice with CLP group [WT (CLP), 50 mice], WT mice with CLP and subcutaneous injection of 200 mg/Kg parenteral Vit C group [WT (CLP + Vit C), 50 mice], [Gulo.sup.-/-] mice with CLP group [[Gulo.sup.-/-] (CLP), 50 mice], and [Gulo.sup.-/-] mice with CLP and subcutaneous injection of 200 mg/Kg parenteral Vit C group [[Gulo.sup.-/-] (CLP + Vit C), 50 mice].
Parenteral packaging market is growing, this is attributed to growing population, rising prevalence of diseases, increasing government funding for immunization across the globe, increasing companies investment in vaccine development, and rising initiatives by non-government organizations for vaccinations, which ultimately aids the growth of the parenteral packaging market, as more number of pharmaceutical companies buying the packaging containers.
The CDC-recommended treatment, parenteral quinidine (given with a second drug: doxycycline, tetracycline, or clindamycin), is the only Federal Drug Administration (FDA)--approved parenteral antimalarial regimen currently available in the United States.
This form of nutrition is called Total Parenteral Nutrition (TPN).
Parenteral nutrition entails infusion of intravenous nutrients (macronutrients and micronutrients) to patients who have contraindications to an oral dietary approach.
One study which looked at this issue (3) switched 24 patients (17 females) from oral MTX (mean = 17.5 mg/week) to parenteral MTX (mean = 15 mg/week) and saw that 20 of them improved, where 3 were unchanged, and only one patient got worse.
In a phase III study of 86 adults with SBS, 63% of those treated with 0.05 mg/kg daily had at least a 20% reduction in the volume of parenteral nutrition and IV fluids required after 24 weeks of treatment, compared with 30% of those on placebo.
Pharmaceutical Processing: What is the current thinking regarding safely and cleanly handling and transporting parenteral products?
Purpose: Due to multiple court cases regarding the labelling of anthroposophic preparations in parenteral dosage forms containing mistletoe the Federal Institute For Drugs and Medical Devices (BfArM) invited the anthroposophic Marketing Authorization Holders (MAHTs) to discuss a compromise resulting in a revision of the standard Summary of Product Characteristic (SPC) for all relevant preparations.